Opioids: Digital Therapeutics

Midwest CEPAC

ICER will assess the comparative clinical effectiveness and economic value of digital therapeutics for opioid use disorder. ICER has reviewed other related topics, such as abuse-deterrent opioid formulations, medication-assisted treatment for opioid use disorder, and non-drug interventions for lower back pain.

This review reinforces ICER’s commitment to provide an independent evaluation of the evidence around interventions that target the public health crises stemming from the opioid epidemic in the United States.

Review date: November 2020 

For more information, please contact Zunelly Odhiambo, Program Manager, at zodhiambo@icer-review.org.

Associated Meetings

November 18, 2020 9:00 am - 1:30pm CT

Virtual

The Midwest CEPAC will convene virtually to deliberate and vote on evidence presented in ICER's report on digital therapeutics for opioid use disorder (OUD).


Key Dates

Associated Materials

02/21/2020 – 03/10/2020

03/13/2020

03/13/2020 – 06/01/2020

03/13/2020

06/12/2020

07/14/2020

08/03/2020

09/17/2020

09/17/2020

09/17/2020 – 10/15/2020
Public Comments

11/06/2020
Revised Voting Questions

11/06/2020
Response to Public Comments

11/06/2020
Evidence Report

11/20/2020

11/20/2020
Evidence Presentation

12/15/2020
Final Evidence Report and Meeting Summary

12/15/2020
Report-at-a-Glance

12/15/2020
Final Policy Recommendations